Madison Park Group is a unique investment banking firm that takes a "strategy first" approach to advising technology companies. Our partners have developed and advised numerous successful companies in the enterprise software / SaaS sector as operators, investors and investment bankers. We believe transformative outcomes are driven by blending practical financial advice and hands-on operational experience. This unique skill-set helps founders and investors navigate complex strategic initiatives such as buy- and sell-side M&A and mezzanine debt and equity financings. Our partners have been instrumental in over 200 M&A and financing transactions over the past 20 years.
Follow us on LinkedIn to keep up to date with all of our transactions and publications.
October 29, 2020. Madison Park Group (MPG) is pleased to announce the release of its October 2020 Life Sciences Software Market Snapshot. Please click [here] for access to the report.
The onset of the COVID-19 pandemic catalyzed accelerated adoption of frontier technologies in the life sciences software ecosystem, with a heavy focus on virtual trial capabilities. While the pandemic led to a temporary slowdown in transaction activity for a few weeks in early 2020, the fundamental technology shifts in the life sciences market have sparked a recent resurgence of M&A and investment appetite. We foresee strong continued interest in this sector in the coming months.
MPG’s practice in life sciences software is spearheaded by Rohan Khanna and Jonathan Adler. Mr. Khanna commented, “We are witnessing accelerated innovation and investment in the life sciences market and are excited about the opportunities it presents, both for established players and rising stars. Our constant monitoring of the market coupled with our deep transaction experience enables us to guide clients as they navigate through a rapidly changing ecosystem and pursue their long-term strategic goals.”
MPG actively tracks the life sciences software landscape and have noticed a number of market dynamics: